Medicare Enrolled
Dr. Christopher Miller, M.D.
Urology Physician · Lancaster, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Research-focused
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Miller from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Miller?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Miller
Dr. Christopher Miller is an urology physician in Lancaster, PA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Miller performed 5,171 Medicare services across 1,982 unique beneficiaries.
Between the years covered by Open Payments, Dr. Miller received a total of $18,887 from 42 pharmaceutical and/or device companies across 149 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are classified as research and scientific activities (grants and research funding). Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Miller is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 9% volume in PA
$18,887 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,171
Medicare services
Top 9% in PA for urology physician
1,982
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~398 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,875 | $0 | $3 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
452 | $2 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
398 | $87 | $210 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
302 | $62 | $139 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
246 | $7 | $41 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
152 | $76 | $316 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
122 | $38 | $84 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
113 | $59 | $585 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
67 | $63 | $201 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
63 | $3 | $20 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
63 | $119 | $323 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
46 | $18 | $260 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
42 | $316 | $1,052 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
31 | $39 | $249 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
26 | $194 | $800 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
24 | $63 | $210 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
23 | $268 | $594 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
23 | $89 | $327 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
23 | $100 | $281 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
22 | $24 | $559 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
20 | $8 | $209 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
19 | $145 | $419 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
19 | $113 | $884 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.2% high complexity
65.1% medium
33.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$18,887
Total received (2018-2024)
Avg $2,698/year across 7 years
Top 8% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
149
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Scientific / Research
Research funding and grants
$15,000 (79.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,593 (19.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$294 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$755
2023
$670
2022
$783
2021
$15,433
2020
$75
2019
$457
2018
$712
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$148
Axonics, Inc.
$119
AstraZeneca Pharmaceuticals LP
$111
Teleflex LLC
$102
Merck Sharp & Dohme LLC
$54
BLUEWIND MEDICAL
$37
COLOPLAST CORP
$35
PROGENICS PHARMACEUTICALS, INC.
$29
180 Medical, Inc.
$27
Ambu Inc.
$24
Sumitomo Pharma America, Inc.
$21
Astellas Pharma US Inc
$17
Verity Pharmaceuticals Inc.
$17
Myriad Genetic Laboratories, Inc.
$15
Top 3 companies account for 50.0% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$15,000
AstraZeneca Pharmaceuticals LP
$450
Astellas Pharma US Inc
$430
BOSTON SCIENTIFIC CORPORATION
$391
NeoTract Inc.
$317
Teleflex LLC
$280
UROVANT SCIENCES INC
$216
Merck Sharp & Dohme LLC
$167
Axonics, Inc.
$150
ABBVIE INC.
$148
PFIZER INC.
$138
Boston Scientific Corporation
$124
TOLMAR Pharmaceuticals, Inc.
$115
180 Medical, Inc.
$80
Agiliti Surgical, Inc.
$73
Dendreon Pharmaceuticals LLC
$72
Foundation Medicine, Inc.
$61
Sumitomo Pharma America, Inc.
$56
Merck Sharp & Dohme Corporation
$52
Travere Therapeutics, Inc.
$40
Janssen Biotech, Inc.
$39
Ferring Pharmaceuticals Inc.
$38
BLUEWIND MEDICAL
$37
COLOPLAST CORP
$35
Verity Pharmaceuticals Inc.
$33
Bayer HealthCare Pharmaceuticals Inc.
$32
PROGENICS PHARMACEUTICALS, INC.
$29
Tolmar, Inc.
$29
Myriad Genetic Laboratories, Inc.
$28
Ambu Inc.
$24
SUN PHARMACEUTICAL INDUSTRIES INC.
$22
Medtronic USA, Inc.
$21
Novartis Pharmaceuticals Corporation
$21
Baxter Healthcare
$20
Sun Pharmaceutical Industries Inc.
$19
UroGen Pharma, Inc.
$18
Telix Pharmaceuticals
$17
ACCORD HEALTHCARE, INC.
$17
KARL STORZ Endoscopy-America
$15
E.R. Squibb & Sons, L.L.C.
$12
Myovant Sciences Inc.
$11
UROGEN PHARMA, INC.
$11
Top 3 companies account for 84.1% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AMS · AUTOCLAV · Axonics · BOTOX · CAMCEVI · ELIGARD · ERLEADA · Erleada · FIRMAGON · FOUNDATIONONE · Flexiva · GEMTESA · GENERAL BPH · GENERAL ERECTILE DYSFUNCTION · HOPKINS II · ILLUCCIX · INTERSTIM · JELMYTO · KEYTRUDA · LITHOVUE · LYNPARZA · MYRBETRIQ · Myrbetriq · NOCDURNA · Nubeqa · OPDIVO · ORGOVYX · PROLARIS · PROVENGE · PYLARIFY · Porges Coloplast · REVI · SYNCHROMED · Sonablate · SpeediCath · TELESCOPE · TISSEEL · Thiola · Trelstar · UROLIFT · UroLift · XTANDI · Xtandi · YONSA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (79%) are classified as scientific/research, suggesting involvement in clinical studies, grants, or innovation-related work. Total industry engagement is in the top 8% for urology physician in PA.
Geographic Context
Urology physicians within 10 mi
48
Per 100K population
8.6
County median income
$83,703
Nearest hospital
PENN STATE HEALTH LANCASTER MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Miller is a clinical cardiology specialist, with above-average Medicare volume (top 9% in PA), with research-focused industry engagement in the top 8% of PA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Miller experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Miller performed 2,875 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Miller receive payments from pharmaceutical companies?
Yes. Dr. Miller received a total of $18,887 from 42 companies across 149 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Miller's costs compare to other urology physicians in Lancaster?
Dr. Miller's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Miller) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Lancaster
Browse urology physicians in Lancaster ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology